Why it is important to align chromatograms when collecting data from both a PDA and a QDa mass detector?
Let me show you.
How do I extract chromatograms and spectra while in the Mass Analysis window?
I thought you’d never ask. Learn how.
Did you know that you could work with MS data from an ACQUITY QDa Mass Detector in Empower? Read more and learn how.
Learn how the ACQUITY QDa Mass Detector brings the power of mass detection for purification to Medicilon, helping this CRO meet the growing demand for outsourced services in the pharmaceutical and biotechnology industries.
In Japan, Professor Masanori Kataoka finds that the ACQUITY QDa Mass Detector is suitable for the synthesis and analysis of oligonucleotides – and sees ways to expand its use.
There are two primary multi-attribute monitoring (MAM) assay choices for biologic development and QC: subunit protein mass analysis and peptide mapping by LC-MS. Here we explore how peptide mapping LC-MS MAM workflows are being used.
If data can throw your biotherapeutic development program into chaos, it can also help move you forward. Let’s see how.
The improvements in LC-MS technology under GxP compliant-ready informatics for biopharmaceutical analysis has prepared the industry to expand the role of MS technologies beyond product characterization toward monitoring product and process quality attributes.
You won’t like what we found when we tested skin lightening cosmetics that we purchased online.
Choosing the right technology is crucial – so it’s great when innovation makes the decision clear-cut. With Gerard Rosse, Associate Director, Structure Guided Chemistry at Dart NeuroScience.